Precision Microwave was founded in April 2017 following successful completion of a Nation Science Foundation I-Corps program where the founding team interviewed over 120 physicians, nurses, hospital administrators, and others to study the clinical needs and pain points with existing MWA systems. Since its inception, Precision Microwave has worked diligently on developing the next generation of microwave ablation technology that will give doctors the flexibility and control they need to treat dramatically more patients and medical conditions with a minimally invasive procedure. Precision Microwave was awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I grant in July 2018. In May 2020 Precision Microwave received a subsequent Phase II Small Business Innovation Research (SBIR) grant from the NSF to continue efforts to commercialize its directional ablation applicator and system.
Precision Microwave is located in Manhattan, Kansas in an independent office and lab space purpose-built to meet our R&D needs. Precision Microwave maintains close collaborative relationships with a network of physicians specialized in thermal ablation procedures as well as the Kansas State University Colleges of Engineering and Veterinary Medicine.
Company’s Keywords:
<2
<
<2017
Your request has been submitted successfully.
Own or work here?